Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The spreading of pathology within and between brain areas is a hallmark of neurodegenerative disorders. In patients with Alzheimer’s disease, deposition of amyloid-β is accompanied by activation of the innate immune system and involves inflammasome-dependent formation of ASC specks in microglia. ASC specks released by microglia bind rapidly to amyloid-β and increase the formation of amyloid-β oligomers and aggregates, acting as an inflammation-driven cross-seed for amyloid-β pathology. Here we show that intrahippocampal injection of ASC specks resulted in spreading of amyloid-β pathology in transgenic double-mutant APPSwePSEN1dE9 mice. By contrast, homogenates from brains of APPSwePSEN1dE9 mice failed to induce seeding and spreading of amyloid-β pathology in ASC-deficient APPSwePSEN1dE9 mice. Moreover, co-application of an anti-ASC antibody blocked the increase in amyloid-β pathology in APPSwePSEN1dE9 mice. These findings support the concept that inflammasome activation is connected to seeding and spreading of amyloid-β pathology in patients with Alzheimer’s disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-1 beta was shown to exacerbate tau pathologies [97] and reduce microglial phagocytic activity [92,93,94].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [94]
In the citing paper
“Rat research has identified the NLRP3-ASC inflammasome as a major mechanism through which microglia may drive pathological features of AD [92,93,94].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [94]
In the citing paper
“In turn, the NLRP3 inflammasome is essential for the development and progression of Aβ pathology in mice29 and may drive tau pathology through Aβ-induced microglial activation30.”
From New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) · cites this paper as [29]
In the citing paper
“Pyroptosis of glial cells leads to release of ASC specks into the extracellular space, where it binds rapidly to Aβ peptides, increasing the aggregation of Aβ.357”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [357]
In the citing paper
“In that study, ASC-bound Aβ was detected in brain samples from AD patients, but not in samples from age-matched controls without dementia.”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [80]
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Self-citationScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Self-citationUnified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Lu, A., Magupalli, V. G., Ruan, J., Yin, Q., Atianand, M. K., Vos, M. R., Schröder, G. F., Fitzgerald, K. A., Wu, H., & Egelman, E. H. (2014) · Cell · doi:10.1016/j.cell.2014.02.008 · Cited by 1,353
Cited by
Items 101–200 of 1,002
Pellegrini, C., Antonioli, L., Calderone, V., Colucci, R., Fornai, M., & Blandizzi, C. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101806 · Cited by 174
NLRP3 inflammasome activation in inflammaging
Latz, E., & Duewell, P. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.001 · Cited by 174
Self-citationDo infections have a role in the pathogenesis of Alzheimer disease?
Itzhaki, R. F., Golde, T. E., Heneka, M. T., & Readhead, B. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0323-9 · Cited by 171
Self-citationXu, Y., Propson, N. E., Du, S., Xiong, W., & Zheng, H. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2023418118 · Cited by 171
“Since increased IL1β is often associated with inflammasome activation (29, 35), we next tested whether inflammasome is activated in Atg7 KO microglia.”
BackgroundMethodNeuroimmune Connections in Aging and Neurodegenerative Diseases
Scheiblich, H., Trombly, M., Ramirez, A., & Heneka, M. T. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.02.002 · Cited by 166
Self-citationMicroglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer’s disease
van Olst, L., Simonton, B., Edwards, A. J., Forsyth, A. V., Boles, J. S., Jamshidi, P., Watson, T. H., Shepard, N., Krainc, T., Argue, B. M., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03574-1 · Cited by 186
“PYCARD activates the inflammasome, forming apoptosis-associated speck-like protein containing a CARD (ASC) specks that can cross-seed Aβ pathology 37 .”
The NLRP3 inflammasome triggers sterile neuroinflammation and Alzheimer’s disease
Milner, M. T., Maddugoda, M., Götz, J., Burgener, S. S., & Schroder, K. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.10.011 · Cited by 161
Ivanova, M. I., Lin, Y., Lee, Y., Zheng, J., & Ramamoorthy, A. (2020) · Biophysical Chemistry · doi:10.1016/j.bpc.2020.106507 · Cited by 161
Tapia‐Abellán, A., Angosto-Bazarra, D., Alarcón‐Vila, C., Baños, M. C., Hafner‐Bratkovič, I., Oliva, B., & Pelegrín, P. (2021) · Science Advances · doi:10.1126/sciadv.abf4468 · Cited by 165
Zhong, G., Long, H., Zhou, T., Liu, Y., Zhao, J., Han, J., Yang, X., Yu, Y., Chen, F., & Shi, S. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121690 · Cited by 151
Glial cells in Alzheimer’s disease: From neuropathological changes to therapeutic implications
Uddin, M. S., & Lim, L. W. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101622 · Cited by 145
NLRP3 inflammasome in neurodegenerative disease
Anderson, F. L., Biggs, K. E., Rankin, B. E., & Havrda, M. C. (2022) · Translational research · doi:10.1016/j.trsl.2022.08.006 · Cited by 162
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Wang, M., Zhang, H., Liang, J., Huang, J., & Chen, N. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02753-6 · Cited by 162
Inflammatory pathways in Alzheimer’s disease mediated by gut microbiota
Qian, X.-H., Song, X.-X., Liu, X.-L., Chen, S.-D., & Tang, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101317 · Cited by 153
Inflammatory aspects of Alzheimer’s disease
Lucena, P. B., & Heneka, M. T. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02790-2 · Cited by 166
“Released extracellular ASC specks not only propagate inflammation to surrounding cells [68] but bind Aβ acting like “seeds”, accelerating the ongoing amyloidogenic process [69, 239] (Fig.”
Self-citationThioredoxin-Interacting Protein (TXNIP) with Focus on Brain and Neurodegenerative Diseases
Tsubaki, H., Tooyama, I., & Walker, D. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249357 · Cited by 161
“It was shown in AD plaque-developing mice that injection of brain-derived ASC specks produced upon inflammasome activation promoted the seeding of Aβ plaques in brains [128].”
BackgroundMicroglial polarization: novel therapeutic mechanism against Alzheimer’s disease
Yao, K., & Zu, H. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00613-5 · Cited by 158
Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease
Wu, S., Liu, X., Jiang, R., Yan, X., & Ling, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.650047 · Cited by 143
Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets
Nizami, S., Hall‐Roberts, H., Warrier, S., Cowley, S. A., & Di Daniel, E. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14618 · Cited by 147
Microglia in Alzheimer's Disease: Risk Factors and Inflammation
Katsumoto, A., Takeuchi, H., Takahashi, K., & Tanaka, F. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00978 · Cited by 136
Fundamentals of cross-seeding of amyloid proteins: an introduction
Ren, B., Zhang, Y., Zhang, M., Liu, Y., Zhang, D., Gong, X., Feng, Z., Tang, J., Chang, Y., & Zheng, J. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01871a · Cited by 146
Fulp, J., Liu, H., Toldo, S. A., Jiang, Y., Boice, A., Guo, C., Li, X., Rolfe, A., Sun, D., Abbate, A., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00733 · Cited by 139
Fu, W.-Y., Wang, X., & Ip, N. Y. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00402 · Cited by 133
Soluble α-synuclein–antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia
Trudler, D., Nazor, K. L., Eisele, Y. S., Grabauskas, T., Dolatabadi, N., Parker, J., Sultan, A., Zhong, Z., Goodwin, M. S., Levites, Y., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025847118 · Cited by 131
“For example, Aβ may provide additional secondary signal for NLRP3 inflammasome activation (62).”
Backgroundα‐Synuclein evokes NLRP3 inflammasome‐mediated IL‐1β secretion from primary human microglia
Pike, A. F., Varanita, T., Herrebout, M. A. C., Plug, B. C., Kole, J., Musters, R. J. P., Teunissen, C. E., Hoozemans, J. J. M., Bubacco, L., & Veerhuis, R. (2021) · Glia · doi:10.1002/glia.23970 · Cited by 126
Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases
Miller, A. L., Bessho, S., Grando, K. C. M., & Tükel, Ç. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.638867 · Cited by 141
Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
Sanchez-Varo, R., Mejias-Ortega, M., Fernandez-Valenzuela, J. J., Nuñez-Diaz, C., Caceres-Palomo, L., Vegas-Gomez, L., Sanchez-Mejias, E., Trujillo-Estrada, L., Garcia-Leon, J. A., Moreno-Gonzalez, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105404 · Cited by 129
NLRP3 inflammasome signalling in Alzheimer's disease
McManus, R. M., & Latz, E. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109941 · Cited by 144
“As a large protein complex, ASC can also act as a seed for proteins to attach to thus contributing to its inflammatory activity (Venegas et al., 2017; Friker et al., 2020).”
Self-citationMitochondria at the interface between neurodegeneration and neuroinflammation
Bader, V., & Winklhofer, K. F. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.05.028 · Cited by 132
Zhang, B., Chen, H., Ouyang, J., Xie, Y., Chen, L., Tan, Q., Du, X., Su, N. Y., Ni, Z., & Chen, L. (2019) · Autophagy · doi:10.1080/15548627.2019.1664705 · Cited by 142
“inflammasome and involves in the production of mature IL1B [28].”
BackgroundNeuropathogenesis-on-chips for neurodegenerative diseases
Amartumur, S., Nguyen, H. M., Huynh, T., Kim, T. S., Woo, R., Oh, E., Kim, K. K., Lee, L. P., & Heo, C. (2024) · Nature Communications · doi:10.1038/s41467-024-46554-8 · Cited by 143
“Increased production of NLRP3 accelerates the activity of caspase-1 and secretion of proin-fl ammatory cytokines, such as IL-1 β and IL-18, and promotes neuronal and glial death via apoptosis 127,128 .”
BackgroundMechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease
Welch, G., & Tsai, L. (2022) · The EMBO Reports · doi:10.15252/embr.202154217 · Cited by 129
“In particular, microglial NLRP3 has been shown to be a major driver of amyloid beta and tau toxicity in AD, suggesting its activation has important implications for disease progression (Halle et al , 2008; Venegas et al , 2017; Ising et al , 2019).”
Inflammatory mechanisms in neurodegeneration
Nichols, M. R., St‐Pierre, M., Wendeln, A., Makoni, N. J., Gouwens, L. K., Garrad, E. C., Sohrabi, M., Neher, J. J., Tremblay, M., & Combs, C. K. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14674 · Cited by 121
“…protein containing a CARD, which forms aggregates (so called specks) upon inflammasome activation and can subsequently be released from microglia, was implicated in cross-seeding Ab pathology (Venegas et al. 2017), suggesting another microglial mechanism in the modulation of cerebral b-amyloidosis.”
BackgroundMicroglial phagocytosis in aging and Alzheimer's disease
Gabandé‐Rodríguez, E., Keane, L., & Capasso, M. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24419 · Cited by 127
The Early Events That Initiate β-Amyloid Aggregation in Alzheimer’s Disease
Zhang, X., Fu, Z., Meng, L., He, M., & Zhang, Z. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00359 · Cited by 122
Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer’s Disease
Zhang, Y., Zhao, Y., Zhang, J., & Yang, G. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03121-z · Cited by 131
“However, ASC deficiency or the application of ASC antibodies led to less Aβ deposition in the brain and improvements in spatial-memory in APP/PS1 mice [84].”
BackgroundCrosstalk Between Dysfunctional Mitochondria and Inflammation in Glaucomatous Neurodegeneration
Jassim, A. H., Inman, D. M., & Mitchell, C. H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.699623 · Cited by 127
The role of innate immunity in Alzheimer's disease
Ennerfelt, H. E., & Lukens, J. R. (2020) · Immunological Reviews · doi:10.1111/imr.12896 · Cited by 119
Cell Death and Neurodegeneration
Andreone, B. J., Larhammar, M., & Lewcock, J. W. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a036434 · Cited by 132
“…to what was observed with α-syn mediated activation of parthanatos in neurons (Kam et al. 2018), NLRP3 inflammasome activation in microglia has been shown to propagate Aβ aggregation and spreading, creating a positive feedback loop that may exacerbate neuronal cell death (Venegas et al. 2017).”
BackgroundRevisiting the Hallmarks of Aging to Identify Markers of Biological Age
Guerville, F., De Souto Barreto, P., Ader, I., Andrieu, S., Casteilla, L., Dray, C., Fazilleau, N., Guyonnet, S., Langin, D., Liblau, R., et al. (2020) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2019.50 · Cited by 116
“As cholesterol crystals and β-amyloid proteins can trigger assembly of inflammasome complexes, this pathway is involved in atherosclerosis lesion progression (80) and neuro-inflammation in AD (81,82).”
BackgroundTherapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases
Seok, J. K., Kang, H. C., Cho, Y., Lee, H. S., & Lee, J. Y. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01307-9 · Cited by 133
Pharmacological approaches to mitigate neuroinflammation in Alzheimer’s disease
Uddin, M. S., Kabir, M. T., Mamun, A. A., Barreto, G. E., Rashid, M., Perveen, A., & Ashraf, G. M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106479 · Cited by 114
Microglial Calhm2 regulates neuroinflammation and contributes to Alzheimer’s disease pathology
Cheng, J., Dong, Y., Ma, J., Pan, R., Liao, Y., Kong, X., Li, X., Li, S., Chen, P., Wang, L., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe3600 · Cited by 116
Miao, J., Chen, L., Pan, X., Li, L.-Q., Zhao, B., & Lan, J. X. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01376-y · Cited by 129
“Activation of the NLRP3 inflammasome in microglia leads to the release of pro-inflammatory cytokines, such as IL-1β and IL-18, which contribute to neuroinflammation and neuronal damage (Venegas et al. 2017).”
BackgroundGut microbiota–driven brain Aβ amyloidosis in mice requires microglia
Dodiya, H. B., Lutz, H. L., Weigle, I. Q., Patel, P., Michalkiewicz, J., Roman-Santiago, C. J., Zhang, C. M., Liang, Y., Srinath, A., Zhang, X., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20200895 · Cited by 120
Chen, S., Zhou, H., Zhang, G., Meng, J., Deng, K., Zhou, W., Wang, H., Wang, Z., Hu, N., & Suo, Y. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b06402 · Cited by 126
The role of the immune system in Alzheimer’s disease
Wu, K., Zhang, Y.-R., Huang, Y., Dong, Q., Tan, L., & Yu, J. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101409 · Cited by 127
Chiral nanoparticle-remodeled gut microbiota alleviates neurodegeneration via the gut–brain axis
Guo, X. L., Li, C., Zhang, J., Sun, M., Xu, J., Xu, C., Kuang, H., & Xu, L. (2023) · Nature Aging · doi:10.1038/s43587-023-00516-9 · Cited by 124
Neuroinflammation in mouse models of Alzheimer's disease
Saito, T., & Saido, T. C. (2018) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12475 · Cited by 117
“To this end, microglia-derived ASC (a constituent of the inflammasome) has been shown to regulate amyloidosis in APPswe/PSEN1dE9 mice.(35) Modulation of glial function through the manipulation of cytokines/chemokines and their receptors has also been investigated.”
BackgroundMilligan Armstrong, A., Porter, T., Quek, H., White, A., Haynes, J., Jackaman, C., Villemagne, V., Munyard, K., Laws, S. M., Verdile, G., et al. (2021) · Biological Reviews · doi:10.1111/brv.12750 · Cited by 116
Guedes, J. R., Lao, T., Cardoso, A. L., & El Khoury, J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00549 · Cited by 115
Lee, S. W., de Rivero Vaccari, J. P., Truettner, J. S., Dietrich, W. D., & Keane, R. W. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1423-6 · Cited by 114
“The recent discovery that anti-ASC binds to ASC specks and reduces the amount of Aβ monomers and oligomers leading to decreased Aβ deposition [77] suggests that inhibiting ASC may also target progressive pathophysiological mechanisms leading to post-traumatic neurodegenerative disorders including Alzheimer’s disease a…”
BackgroundAmyloid Cross-Seeding: Mechanism, Implication, and Inhibition
Subedi, S., Sasidharan, S., Nag, N., Saudagar, P., & Tripathi, T. (2022) · Molecules · doi:10.3390/molecules27061776 · Cited by 122
Pellegrini, C., Fornai, M., Antonioli, L., Blandizzi, C., & Calderone, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122876 · Cited by 104
“In particular, they observed that NLRP3 activation in the brain from AD mice promoted the release of ASC speck proteins in the extracellular space, which, in turn, rapidly bounded Aβ peptides, leading to an increase in its aggregation and accumulation [76].”
BackgroundInflammasomes in neurological disorders — mechanisms and therapeutic potential
Ravichandran, K. A., & Heneka, M. T. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-023-00915-x · Cited by 117
“In various mouse models of AD that develop either amyloidosis (APP/PS1, 3×transgenic (3×Tg) AD mice and 5×FAD mice) or tauopa-thy (THY-Tau22 and tauP301S), NLRP3 inflammasome activity is increased in the brain 2,49–55 (Table 1).”
InfluentialSelf-citationMitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First?
Peggion, C., Calí, T., & Brini, M. (2024) · Antioxidants · doi:10.3390/antiox13020240 · Cited by 124
“…fl ammasome See Figure 3. activation 10 of 19 A major consequence of AD neuroin fl ammation is that A β - induced microglial NLRP3 in fl ammasome activation results in the extracellular release of ASC specks, which may act as binding cores for A β , promoting the formation and propagation [156,157].”
BackgroundResultNeuroinflammation, Its Role in Alzheimer's Disease and Therapeutic Strategies
Király, M., Foss, J. F., & Giordano, T. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.109 · Cited by 122
“TREM2 is a receptor that activates upon the stimulation of the immunoreceptor tyrosine-based motif (ITAM) pathway, thus causing microglia to become reactive (32).”
BackgroundSGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models
Kwon, O., Song, J., Yang, Y., Kim, S., Kim, J. Y., Seok, M., Hwang, I., Yu, J., Karmacharya, J., Maeng, H., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013076 · Cited by 110
“…has lately been reported as a central pathogenic contributor to neurodegenerative diseases (Voet et al , 2019), including AD (Heneka et al , 2013; Venegas et al , 2017; Ising et al , 2019) and PD (Mao et al , 2017; Lee et al , 2018), further indicating that SGK1 inhibition in glia could be a…”
Fisch, D., Clough, B., Domart, M., Encheva, V., Bando, H., Snijders, A. P., Collinson, L., Yamamoto, M., Shenoy, A. R., & Frickel, E. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108008 · Cited by 115
Inflammatory Cascade in Alzheimer’s Disease Pathogenesis: A Review of Experimental Findings
de Oliveira, J., Kucharska, E., Garcez, M. L., Rodrigues, M. S., Quevedo, J., Moreno-Gonzalez, I., & Budni, J. (2021) · Cells · doi:10.3390/cells10102581 · Cited by 102
“These particles can also bind to Aβ, contributing to its aggregation [98].”
Li, T., Lu, L., Pember, E., Li, X., Zhang, B., & Zhu, Z. (2022) · Cells · doi:10.3390/cells11121925 · Cited by 104
“In contrast, NLRP3 inflammasome activation exacerbates amyloid pathology in vivo by prion-like ASC-speck cross-seeding [75].”
BackgroundIncreasing complexity of NLRP3 inflammasome regulation
Moretti, J., & Blander, J. M. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0520-104rr · Cited by 114
Restoring regulatory T-cell dysfunction in Alzheimer’s disease through ex vivo expansion
Faridar, A., Thome, A. D., Zhao, W., Thonhoff, J. R., Beers, D. R., Pascual, B., Masdeu, J. C., & Appel, S. H. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa112 · Cited by 104
“This subtype is characterized by a unique expression profile consisting of up-regulation of certain inflammatory genes and down-regulation of homeostatic gene expressions (Venegas et al., 2017; Del-Aguila et al., 2019; Mathys et al., 2019; Gray et al., 2020).”
BackgroundBassil, R., Shields, K., Granger, K., Zein, I., Ng, S., & Chih, B. (2021) · Nature Communications · doi:10.1038/s41467-021-25344-6 · Cited by 106
Microglia in Alzheimer’s disease: A target for immunotherapy
Wang, S., & Colonna, M. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0818-319r · Cited by 105
Liang, C., Zou, T., Zhang, M., Fan, W., Zhang, T., Jiang, Y., Cai, Y., Chen, F., Chen, X., Sun, Y., et al. (2021) · Theranostics · doi:10.7150/thno.53418 · Cited by 102
“Microglia-Aβ interactions lead to early synapse loss, production of neurotoxic reactive oxygen and nitrogen species (ROS and RNS), NLRP3 inflammasome activation, and production of pro-inflammatory cytokines and TNF27 [24-27].”
BackgroundMicroglial mitophagy mitigates neuroinflammation in Alzheimer's disease
Lautrup, S., Lou, G., Aman, Y., Nilsen, H., Tao, J., & Fang, E. F. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104469 · Cited by 105
“…of these findings, previous studies have shown that neuroinflammation in the form of greater frequency of activated microglia in close vicinity of Aβ plaques; thereby reinforcing the link between microglial activation and neuroinflammation in AD (Bamberger et al., 2003; Venegas et al., 2017).”
ResultThe Inflammasome in Times of COVID-19
Vaccari, J. C. D. R., Dietrich, W. D., Keane, R. W., & Vaccari, J. P. D. R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583373 · Cited by 110
Flores, J., Noël, A., Foveau, B., Beauchet, O., & LeBlanc, A. C. (2020) · Nature Communications · doi:10.1038/s41467-020-18405-9 · Cited by 97
Pyroptosis, and its Role in Central Nervous System Disease
Hu, Y., Wang, B., Li, S., & Yang, S. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167379 · Cited by 108
Microglia and Astrocytes in Alzheimer’s Disease: Significance and Summary of Recent Advances
Deng, Q., Wu, C., Parker, E., Liu, T. C.-Y., Duan, R., & Yang, L. (2023) · Aging and disease · doi:10.14336/ad.2023.0907 · Cited by 102
Gabandé‐Rodríguez, E., Heras, M. M. G. D. L., & Mittelbrunn, M. (2019) · Cells · doi:10.3390/cells9010082 · Cited by 106
Role of pyroptosis in the pathogenesis of various neurological diseases
Oladapo, A., Jackson, T., Menolascino, J., & Periyasamy, P. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.02.001 · Cited by 103
Heneka, M. T., Gauthier, S. G., Chandekar, S. A., Hahn-Pedersen, J. H., Bentsen, M. A., & Zetterberg, H. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02939-9 · Cited by 108
Self-citationThe roles of microglia and astrocytes in neuroinflammation of Alzheimer’s disease
Han, J., Zhang, Z., Zhang, P., Yu, Q., Cheng, Q., Lu, Z., & Zong, S. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1575453 · Cited by 110
“For tau, active NLRP3 inflammasome increases the glycogen synthase kinase-3 β (GSK-3 β ) kinase activity and aggravate tau hyperphosphorylation (Ising et al., 2019; Venegas et al., 2017).”
Pomeshchik, Y., Klementieva, O., Gil, J., Martinsson, I., Hansen, M. G., de Vries, T., Sancho-Balsells, A., Russ, K., Savchenko, E., Collin, A., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.06.001 · Cited by 95
“Cellular pathology was recently examined in iPSC-derived microglia (Konttinen et al., 2019a), a cell type that plays an important role in AD pathology (Venegas et al., 2017).”
BackgroundThe Regulation and Modification of GSDMD Signaling in Diseases
Li, Z., Ji, S., Jiang, M., Xu, Y., & Zhang, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.893912 · Cited by 108
The three cytokines IL-1β, IL-18, and IL-1α share related but distinct secretory routes
Tapia, V. S., Daniels, M. J. D., Palazón‐Riquelme, P., Dewhurst, M. R., Luheshi, N., Rivers‐Auty, J., Green, J., Redondo‐Castro, E., Kaldis, P., López‐Castejón, G., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008009 · Cited by 97
“Recent research has demonstrated that microglia form inflammasomes during Alzheimer’s disease (19), and inflammasomes are implicated in the progression of a number of other neurological and neurodegenerative conditions (20).”
BackgroundBibliometric Analysis of the Inflammasome and Pyroptosis in Brain
Chen, Y., Li, Y., Guo, L., Hong, J., Zhao, W., Hu, X., Chang, C., Liu, W., & Xiong, K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.626502 · Cited by 92
Inflammasome-mediated innate immunity in Alzheimer’s disease
Venegas, C., & Heneka, M. T. (2019) · The FASEB Journal · doi:10.1096/fj.201900439 · Cited by 93
Self-citationSystematic Analysis and Biomarker Study for Alzheimer’s Disease
Li, X., Wang, H., Long, J., Pan, G., He, T., Anichtchik, O., Belshaw, R., Albani, D., Edison, P., Green, E. K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35789-3 · Cited by 87
mTOR-dependent translation amplifies microglia priming in aging mice
Keane, L., Antignano, I., Riechers, S.-P., Zollinger, R., Dumas, A. A., Offermann, N., Bernis, M. E., Russ, J., Graelmann, F., McCormick, P. N., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci132727 · Cited by 86
“Discussion Microglia have been implicated in the pathogenesis of neurodegenerative diseases, fueling their initiation and progression, especially through a heightened ability to respond to activation stimuli, also called priming (73, 74).”
Self-citationLipocalin 2 as a link between ageing, risk factor conditions and age-related brain diseases
Dekens, D. W., Eisel, U. L. M., Gouweleeuw, L., Schoemaker, R. G., Deyn, P. P. D., & Naudé, P. J. W. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101414 · Cited by 99
Jiang, S., Maphis, N. M., Binder, J., Chisholm, D., Weston, L., Duran, W., Peterson, C., Zimmerman, A., Mandell, M. A., Jett, S. D., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109720 · Cited by 92
“In some instances, ASC appeared as a single bright speck inside the cells or multiple specks in the extracellular space in tauopathy samples, indicating the likelihood of inflammasome assembly (Figure 7E) and spreading, as previously described (Venegas et al., 2017).”
Self-citationInflammasome Activation Induces Pyroptosis in the Retina Exposed to Ocular Hypertension Injury
Pronin, A. N., Pham, D. G., An, W., Dvoriantchikova, G., Reshetnikova, G., Qiao, J., Kozhekbaeva, Z. M., Reiser, A. E., Slepak, V. Z., & Shestopalov, V. I. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00036 · Cited by 98
Xie, Z., Lu, H., Yang, S., Zeng, Y., Li, W., Wang, L., Luo, G., Fang, F., Zeng, T., & Cheng, W. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.568423 · Cited by 95
“In particular, the activation of microglia increases the formation of Aβ oligomers and further aggregation (Narayan et al., 2013; Venegas et al., 2017).”
BackgroundPrecision Nutrition for Alzheimer’s Prevention in ApoE4 Carriers
Norwitz, N. G., Saif, N., Ariza, I. E., & Isaacson, R. S. (2021) · Nutrients · doi:10.3390/nu13041362 · Cited by 85
“Turning to inflammation, βhB inhibits the formation of the NLRP3 inflammasome [92,93] that plays a critical role in the DAM phenotype and progression of amyloid and tau pathology in AD [30,31], as discussed above in the section on microglia.”
BackgroundPatten, K. T., Valenzuela, A. E., Wallis, C., Berg, E. L., Silverman, J. L., Bein, K. J., Wexler, A. S., & Lein, P. J. (2021) · Environmental Health Perspectives · doi:10.1289/ehp8905 · Cited by 95
“For example, activated microglia can seed and spread A b plaques (Venegas et al. 2017), and in our study, sex di ff erences in the onset of microglial activation in TgF344-AD rats coincided with sex di ff erences in the initial deposition of A b .”
Uncoupled pyroptosis and IL-1β secretion downstream of inflammasome signaling
Li, Y., & Jiang, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1128358 · Cited by 134
Terzioglu, G., & Young-Pearse, T. L. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00674-9 · Cited by 91
“Co-localization of ASC and Aβ also was found in brain tissue from patients with MCI that preceded AD, indicating that ASC speck-induced Aβ aggregation may occur in the brain [80].”
BackgroundBorggrewe, M., Grit, C., Den Dunnen, W. F. A., Burm, S. M., Bajramovic, J. J., Noelle, R. J., Eggen, B. J. L., & Laman, J. D. (2018) · Glia · doi:10.1002/glia.23517 · Cited by 91
“A recent study suggests that aggregated Aβ sensed by microglia causes inflammasome activation, which contributes to progression and spreading of inflammation and Aβ pathology (Venegas et al., 2017).”
BackgroundKamila, P., Kar, K., Chowdhury, S., Chakraborty, P., Dutta, R., S, S., Singh S, A., & Prajapati, B. G. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.05.005 · Cited by 90
“TREM2 is activated via the immunoreceptor tyrosine-based activation motif (ITAM) pathway, rendering microglia reactive (Venegas et al., 2017) .”
Glucose metabolism, neural cell senescence and Alzheimer's disease
Wang, Q., Duan, L., Li, X., Wang, Y., Guo, W., Guan, F., & Ma, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084351 · Cited by 90
“Moreover, lipopolysaccharides (LPSs) and Aβ induced the senescence of cultured BV2 microglial cells with senescence-like phenotypes, such as growth arrest, increased SA-β-Gal activity, and pro-inflammatory cytokine production, suggesting that senescent microglia are involved in the pathogenesis of AD [63,64].”
BackgroundThe NLRP3 Inflammasome as a Critical Actor in the Inflammaging Process
Sebastian-Valverde, M., & Pasinetti, G. M. (2020) · Cells · doi:10.3390/cells9061552 · Cited by 83
Decoding Mast Cell-Microglia Communication in Neurodegenerative Diseases
Sandhu, J. K., & Kulka, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031093 · Cited by 93
Oxidative stress–mediated neuroinflammation in Alzheimer’s disease
Firdous, S. M., Khan, S. A., & Maity, A. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03188-3 · Cited by 100
“ROS from NOX4 also contributes to the activation of the NLRP3 inflammasome, a driver of both amyloid-β (Venegas et al. 2017) and Tau (Ising et al. 2019) pathology.”
Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients
Anderson, F. L., von Herrmann, K. M., Andrew, A. S., Kuras, Y. I., Young, A. L., Scherzer, C. R., Hickey, W. F., Lee, S., & Havrda, M. C. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-020-00147-6 · Cited by 92
Epigenetics in Alzheimer’s Disease
Gao, X., Chen, Q., Yao, H., Tan, J., Liu, Z., Zhou, Y., & Zou, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.911635 · Cited by 97
Microglial Inflammasome Activation in Penetrating Ballistic-Like Brain Injury
Lee, S. W., Gajavelli, S., Spurlock, M. S., Andreoni, C. B., Vaccari, J. P. D. R., Bullock, M. R., Keane, R. W., & Dietrich, W. D. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5530 · Cited by 92
Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer’s Disease
Laugisch, O., Johnen, A., Maldonado, A., Ehmke, B., Bürgin, W., Olsen, I., Potempa, J., Sculean, A., Duning, T., & Eick, S. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180620 · Cited by 79
“The chronic inflammation primes the microglia to a hyperreactive state being unable to clear misfolded or damaged neuronal proteins [6] and furthermore enhances the aggregation of neuronal proteins such as A (cid:2) 1 - 42 [7].”
Metadata
- Authors
- Venegas, C., Kumar, S., Franklin, B. S., Dierkes, T., Brinkschulte, R., Tejera, D., Vieira-Saecker, A., Schwartz, S., Santarelli, F., Kummer, M. P., Griep, A., Gelpi, E., Beilharz, M., Riedel, D., Golenbock, D. T., Geyer, M., Walter, J., Latz, E., & Heneka, M. T.
- Affiliations
- University of Bonn (DE)
- Max Planck Institute for Biophysical Chemistry (DE)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Heneka, Michael T.
- ORCID
- Venue
- Nature
- Published
- 2017-12
- Volume
- 552
- Issue
- 7685
- Pages
- 355-361
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2777928756
- Semantic Scholar
- cb17ef0ab08a09442fa73b451fad4635f8d4ab3b
- Cited by
- 983
- References
- 33
- Citations by year
- 2026: 90 · 2025: 112 · 2024: 135 · 2023: 129 · 2022: 130 · 2021: 129 · 2020: 108 · 2019: 81 · 2018: 64 · 2017: 1
- FWCI
- 51.62
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by-nc-nd)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- Alzheimer's disease, amyloid-beta, ASC specks, microglia, inflammasome, cross-seeding, amyloid-beta oligomers, innate immunity, neuroinflammation, amyloid-beta aggregation
- MeSH terms
- Protein Domains, Alzheimer Disease, Animals, Antibodies, Female, Hippocampus, Humans, Inflammation, Mice, Inbred C57BL, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Microglia, Mice, Knockout, Mice, CARD Signaling Adaptor Proteins, Presenilin-1, Inflammasomes, Spatial Memory, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.